{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:22Z","timestamp":1791532162736,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.05.036","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:57:04Z","timestamp":1779926224000},"page":"1287.e1-1287.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Female-To-Male Allogeneic Hematopoietic Cell Transplantation on Survival Outcomes Varies by Recipient Age"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6052-5815","authenticated-orcid":false,"given":"Kosuke","family":"Takano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunto","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-8046","authenticated-orcid":false,"given":"Seitaro","family":"Terakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Keino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-3395","authenticated-orcid":false,"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-2994","authenticated-orcid":false,"given":"Shin-ichiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9925-2093","authenticated-orcid":false,"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-5460","authenticated-orcid":false,"given":"Noboru","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ohbiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-9307","authenticated-orcid":false,"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-7857","authenticated-orcid":false,"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.05.036_bib0001","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.thj.6200117","article-title":"Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants","volume":"2","author":"Gratwohl","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.jtct.2026.05.036_bib0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/bmt.2013.151","article-title":"Risk factors and organ involvement of chronic GVHD in Japan","volume":"49","author":"Kanda","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0004","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/bloodadvances.2019000077","article-title":"BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient","volume":"3","author":"Nakasone","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.05.036_bib0005","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3324\/haematol.2015.125294","article-title":"Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy","volume":"100","author":"Nakasone","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.05.036_bib0006","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1182\/blood-2014-11-613323","article-title":"Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans","volume":"125","author":"Nakasone","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0007","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1038\/s41598-023-34442-y","article-title":"Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Tamaki","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2026.05.036_bib0008","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcyt.2024.09.007","article-title":"Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation","volume":"27","author":"Tamaki","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2026.05.036_bib0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/bmt.2016.328","article-title":"Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant","volume":"52","author":"Watkins","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0010","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2003-03-0984","article-title":"Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors","volume":"103","author":"Miklos","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0012","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2015.134551","article-title":"Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes","volume":"101","author":"Nakasone","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.05.036_bib0013","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.199646","article-title":"A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation","volume":"104","author":"Paul","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.05.036_bib0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12026-014-8514-3","article-title":"Clinical impact of H-Y alloimmunity","volume":"58","author":"Popli","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jtct.2026.05.036_bib0015","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood.2023019799","article-title":"Antibody-mediated pathogenesis of chronic GVHD through DBY\/HLA class II complexes and induction of a GVL effect","volume":"142","author":"Umino","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0016","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0017","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2004-01-0200","article-title":"Duration of immunosuppressive treatment for chronic graft-versus-host disease","volume":"104","author":"Stewart","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0018","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0019","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtct.2025.07.004","article-title":"Allogeneic hematopoietic cell donor selection: contemporary Guidelines from the NMDP\/CIBMTR","volume":"31","author":"Jimenez Jimenez","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.05.036_bib0020","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0021","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","article-title":"Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group","volume":"26","author":"Schetelig","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0022","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0024","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0026","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0027","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.036_bib0028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0030","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0031","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0032","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/bloodadvances.2018018291","article-title":"Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?","volume":"2","author":"Robinson","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.05.036_bib0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10522-018-9746-8","article-title":"Organ reserve, excess metabolic capacity, and aging","volume":"19","author":"Atamna","year":"2018","journal-title":"Biogerontology"},{"key":"10.1016\/j.jtct.2026.05.036_bib0034","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tem.2023.03.005","article-title":"Inflammaging: mechanisms and role in the cardiac and vasculature","volume":"34","author":"Ajoolabady","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jtct.2026.05.036_bib0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jtct.2026.05.036_bib0036","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtct.2022.11.012","article-title":"Noninfectious pulmonary complications after hematopoietic stem cell transplantation","volume":"29","author":"Fraebel","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.05.036_bib0037","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/bmt.2013.116","article-title":"Pre-transplant risk factors for cryptogenic organizing pneumonia\/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation","volume":"48","author":"Nakasone","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0038","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12185-021-03282-9","article-title":"Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Onizuka","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0039","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbmt.2007.05.001","article-title":"Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Yoshihara","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41409-020-01121-9","article-title":"Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children","volume":"56","author":"Kang","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.036_bib0041","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12185-011-0802-2","article-title":"Alemtuzumab for the prevention and treatment of graft-versus-host disease","volume":"93","author":"Kanda","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.05.036_bib0042","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/bloodadvances.2022009112","article-title":"Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation","volume":"7","author":"Ueda Oshima","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.05.036_bib0043","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41409-023-02131-z","article-title":"Post-transplantation cyclophosphamide is associated with increased bacterial infections","volume":"59","author":"Ustun","year":"2024","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600429X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600429X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:57:29Z","timestamp":1791529049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600429X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S266663672600429X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.036","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Female-To-Male Allogeneic Hematopoietic Cell Transplantation on Survival Outcomes Varies by Recipient Age","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}